+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene



Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene



Journal of Medical Virology 73(4): 583-588



There are two types of Epstein Barr virus (EBV): EBV-1 and EBV-2, distinguished by genomic polymorphism in the genes encoding the nuclear antigens (EBNA-2, -3A, -3B, -3C). Latent membrane protein 1 (LMP-1) is an EBV protein with known oncogenic properties. Different variants had been described; among them, a 30 base pair (bp) deletion (del-LMP-1) had been reported in benign and malignant pathologies, but there is little information about its frequency in healthy populations. The aim of this study was to determine the distribution of the EBV genotypes and the 30 bp deletion frequency, in EBV healthy carriers from Argentina. Analysis of EBNA-3C and LMP-1 genes were done by polymerase chain reaction (PCR) followed by Southern blot hybridization on DNA of peripheral blood mononuclear cells (PBMCs) from blood bank donors. EBV-1 was present in 75.9% of samples, EBV-2 in 14.6%, and co-infections with both types in 6.5%. The deleted LMP-1 variant was found in 7.4% of analyzed samples, corresponding 3.2% to deleted variant alone and 4.2% to co-infections with non-deleted form. The non-deleted variant was found in 64.6% whereas in the remaining 28%, no PCR product was detected. These results showed that EBV-1 was the more prevalent type in healthy carriers of Argentina, similar to reports from others countries. A predominance of the non-deleted LMP-1 variant was observed. The presence of co-infections with both types and variants demonstrated that healthy individuals may also harbor multiple EBV infections.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012046906

Download citation: RISBibTeXText

PMID: 15221903

DOI: 10.1002/jmv.20129


Related references

Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. American Journal of Pathology 151(3): 805-812, 1997

Epstein-Barr virus in Hodgkins disease Frequency of a 30-bp deletion in the latent membrane protein 1 oncogene in South African patients. International Journal of Cancer 84(4): 449-451, 1999

A deletion variant of the latent membrane protein 1 oncogene of Epstein-Barr virus is associated with transformation of angioimmunoblastic lymphadenopathy into B-immunoblastic lymphoma. Blood 84(10 Suppl. 1): 521A, 1994

Epstein-barr virus in Hodgkin's disease: frequency of a 30-bp deletion in the latent membrane protein (LMP-1) oncogene in South African patients. International Journal of Cancer 84(4): 449-451, 1999

Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas. Blood 88(1): 242-251, 1996

The 30 base pair deletion mutant of the latent membrane protein 1 oncogene of Epstein-Barr virus is associated with transformation of angioimmunoblastic lymphadenopathy into B-immunoblastic lymphoma. British Journal of Haematology 87(Suppl. 1): 223, 1994

Sequence variations of Epstein-Barr virus latent membrane protein-1 in healthy carriers and EBV-associated diseases in Hong Kong. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1027-1028, 2003

CD20 expression and Epstein-Barr virus association in classical Austrian Hodgkins lymphoma Low prevalence of the 30-base pair deletion in the Epstein-Barr virus latent membrane protein-1 gene. Pathology Research and Practice 197(5): 332, 2001

Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing. Journal of Neuro-Oncology 100(2): 271-279, 2010

Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. International Journal of Cancer 72(2): 225-230, 1997

Signal transduction by the Epstein-Barr virus oncogene latent membrane protein 1 (LMP1). Signal Transduction 7(1): 20-33, 2007

Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. Clinical Molecular Pathology 48(4): M184-M187, 1995

Demonstration of Epstein-Barr virus latent membrane protein and the bcl-2 oncogene protein expression in Hodgkins disease. Pathology Research and Practice 193(5-6): 425, 1997

Epstein-Barr virus latent membrane protein-1 oncogene deletions in Spanish paediatric Hodgkins disease. Virchows Archiv 435(3): 295, 1999

Bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopathology (oxford). 25(1): 77-82, 1994